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are indicators of dengue and chikungunya, point to ZIKV 
as the probable cause of several of the reported cases. Fur-
thermore, laboratory-confirmed cases of infection with 
ZIKV were simultaneously identified in other cities within 
metropolitan Salvador (6,7) and in other states in Brazil (8). 
Low diagnosis of ZIKV infection is likely because viremia 
levels among infected patients appear to be low (9).
The spread of ZIKV represents an additional challenge 
for public health systems, particularly because of the risk 
for concurrent transmission of DENV and CHIKV by the 
same vectors, Ae. aegypti and Ae. albopictus mosquitoes, 
which are abundant throughout tropical and subtropical re-
gions. To date, the largest outbreak of chikungunya in Bra-
zil occurred in 2014 in Feira de Santana, Bahia, ≈100 km 
from Salvador, where dengue is also prevalent (10).
This report illustrates the potential for explosive si-
multaneous outbreaks of ZIKV, CHIKV, and DENV in 
the Western Hemisphere and the increasing public health 
effects of Aedes spp. mosquitoes as vectors. The apparent 
increase in reports of Guillain-Barré syndrome during the 
outbreak deserves further investigation to elucidate wheth-
er this syndrome is associated with ZIKV infection. Pub-
lic health authorities in Brazil and neighboring countries 
should plan accordingly.
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To the Editor: In May 2015 an isolate of the recent-
ly emerged variant of rabbit hemorrhagic disease virus 
(RHDV), RHDV2, was identified in an Australian wild rab-
bit (Oryctolagus cuniculus). RHDV2 (also called RHDVb) 
was first described in outbreaks in France in 2010 (1), then 
Italy and Spain in 2011 (2,3) and in Portugal from 2012 
onwards (4). The virus is a genetically and antigenically 
distinct variant of RHDV that is able to partially overcome 
immunity to classical strains of RHDV (1,2). In contrast 
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to case-fatality rates for other strains of RHDV, those for 
RHDV2 infection have been reported to be lower in mature 
rabbits (0%–75% in 1 study, compared with >90% for clas-
sic RHDV infection) (3) but higher (50% in 1 study) in rab-
bit kittens as young as 30 days of age, which are normally 
highly resistant to lethal RHDV infection (2). RHDV2 has 
been reported to spread effectively in domestic rabbits in 
Europe (3); it may be replacing existing strains of RHDV 
that infect wild rabbits on the Iberian Peninsula (5), pos-
sibly because of its ability to partially overcome immunity 
to these strains.
As part of ongoing opportunistic surveillance of 
RHDV field outbreaks, we analyzed 3 isolates from dead 
adult wild rabbits found in the wider Canberra region of 
Australia. The first virus isolate (BlMt-1) came from a rab-
bit found in Australian Capital Territory on May 13, 2015. 
The second isolate (BlueGums-2) was taken 3 days later 
from a rabbit in New South Wales, 50 km north of Canber-
ra. On June 9, another dead rabbit, from which the third iso-
late (BlMt-2) was obtained, was found in the same location 
as the first. The isolates were initially typed by amplifying 
and sequencing the capsid gene (6), and the results were 
confirmed independently in 2 laboratories. Subsequently, 
full-length genome sequencing of the 3 virus isolates was 
performed by amplifying the viral genomes in overlapping 
fragments (6); the fragments were then sequenced by using 
Illumina MiSeq technology (7).
Phylogenetic analysis revealed that 2 isolates, BlMt-
2 and BlueGums-2, were closely related to field strains 
currently circulating in Australia (7) (Figure). Strikingly, 
the third isolate (BlMt-1) was most closely related to an 
RHDV2 variant generated by recombination of the RHDV2 
capsid gene (Figure, panel B) and the RHDV genogroup 1 
nonstructural genes (Figure, panel A), which has recently 
been reported to be circulating in Portugal and the Azores 
(8,9). How the virus variant arrived in Australia is unclear, 
although our analysis indicates that it likely originated in 
southern Europe. 
In 1991, CSIRO imported the Czech351 strain of 
RHDV to assess its potential as a biocontrol tool for con-
trolling the European rabbit, which causes massive eco-
nomic and ecologic damage and is declared a pest species 
in Australia. In 1995, after initial testing in quarantine, the 
virus escaped during field trials being conducted on a coast-
al island through passive fly transmission and subsequently 
spread across the continent. The RHDV2 variant reported 
here has not previously been investigated by CSIRO, and 
the organization did not possess it.
Rabbits are found in ≈70% of the 6.7 million km2 Aus-
tralian continent and Tasmania. However, natural outbreaks 
of RHDV infection are monitored in comparatively few 
locations, and their detection largely relies on opportunis-
tic sampling. To follow the spread of this new variant and 
determine its current range, increased surveillance of out-
breaks of RHDV infection in both wild and domestic rab-
bits in Australia is urgently required. The unique traits of 
strain RHDV2, particularly its ability to overcome immuni-
ty to classical RHDV strains (including vaccine strains) (3) 
and to infect rabbits at a younger age (2), may have wide-
ranging implications for rabbit biocontrol in Australia. In 
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Figure. Maximum-likelihood phylogenetic analysis of the nonstructural protein genes (A) and the capsid gene (B) of rabbit hemorrhagic 
disease virus (RHDV) sequences. The 3 recent Australian field isolates  sequenced for this study (indicated in bold) were aligned 
with representative RHDV and Australian rabbit calicivirus (RCV-A1) sequences from GenBank (accession numbers indicated in taxa 
names). Phylogenetic analysis was conducted separately for both the nonstructural genes (panel A) and the capsid gene (panel B). 
Phylogenies were rooted by using an early European brown hare syndrome virus strain (not shown). Statistical support for individual 
nodes was estimated from 1,000 bootstrap replicates with values shown for only those nodes where the bootstrap support was ≥70% 
(and all major nodes). Phylogenies were constructed by using the general time reversible plus gamma model of nucleotide substitution, 
as determined in jModelTest, by using PhyML(as available in Geneious version 8.1.5; Biomatters Limited, Auckland, New Zealand). 
Scale bars indicate nucleotide substitutions per site.
parallel with similar efforts in Europe, strategies need to be 
developed to protect commercial and pet rabbits.
Tracking the spread of RHDV2 in Australia, in com-
petition with existing field strains, highlights the value 
of Australia’s rabbits and their diseases as a model sys-
tem for emerging infectious diseases. The point releases 
of both myxoma virus and RHDV into large naive host 
populations represent a grand experiment in disease emer-
gence and evolution (10), which provides a unique op-
portunity to study the virulence evolution of emerging 
pathogens as well as their complex interactions with each 
other. It is notable that since the release of RHDV in Aus-
tralia in 1995, strains of 1 viral lineage dominate the viral 
population nationwide despite hundreds of deliberate re-
releases of the original virus strain for local rabbit control, 
which strongly suggests it has a major selective advantage 
(7). That RHDV2 appeared in a wild rabbit is therefore 
remarkable, particularly because Australian field strains 
were spreading simultaneously in the same area. Com-
paring the epidemiology of this strain in Australia to the 
epidemiology of its well-documented spread in Europe 
will provide valuable insights into RHDV epidemiology 
relevant to both continents.
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To the Editor: A traveler returning from the Middle 
East initiated an outbreak of Middle East respiratory syn-
drome (MERS) in South Korea in 2015, which resulted 
in 186 cases and 36 deaths (1–3). We report a case of 
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